1
|
Sureshkumar S, Mustapha F, Yusoff H, Mwangi KJ, Marcus K, Kohlbrenner B, Issom D, Benissa MR, Aebischer-Perone S, Braha N, Candela E, Chhabra KG, Desikachari BR, Dondi A, Etchebehere M, Gathecha G, Kengne AP, Missoni E, Palafox B, Pati S, Madhu PP, Peer N, Quint J, Tabrizi R, Oris M, Beran D, Balabanova D, Etter JF. An Online Survey of the Perceptions of Clinical and Non-Clinical Professionals on Healthcare for Non-Communicable Diseases and COVID-19 Measures During the Pandemic in Malaysia. Int J Public Health 2023; 68:1605861. [PMID: 37304500 PMCID: PMC10247991 DOI: 10.3389/ijph.2023.1605861] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Accepted: 05/15/2023] [Indexed: 06/13/2023] Open
Abstract
Objectives: This study assesses the opinions of health professionals in Malaysia on the disruption of non-communicable disease (NCD) services during the COVID-19 pandemic from March 2020 to January 2022. Methods: We conducted a cross-sectional online survey with 191 non-clinical public health workers and clinical health service workers in Malaysia from November 2021 to January 2022. Participants were recruited by the Malaysian Ministry of Health using major networks including key experts and practitioners. Secondary respondents were subsequently enrolled through snowballing. Results: The most notable issues raised by the survey participants relate to NCD service disruption, the redirection of NCD care resources, and NCD care being overburdened post-pandemic. Respondents also reported accounts of resilience and prompt reaction from the healthcare system, as well as calls for innovation. Conclusion: Most respondents perceived that the challenges arising from COVID-19 were mostly managed well by the healthcare system, which was able to provide the necessary services to NCD patients during this health emergency. However, the study identifies gaps in the health system response and preparedness capacity, and highlights solutions for strengthening NCD services.
Collapse
Affiliation(s)
| | - Feisul Mustapha
- Disease Control Division, Ministry of Health (Malaysia), Putrajaya, Malaysia
| | - Haironi Yusoff
- Department of Medicine and Public Health, Universiti Malaysia Sarawak, Kota Samarahan, Malaysia
| | - Kibachio Joseph Mwangi
- Institute of Global Health, University of Geneva, Geneva, Switzerland
- Department of Non-Communicable Diseases, Ministry of Health (Kenya), Nairobi, Kenya
| | - Kailing Marcus
- Institute of Global Health, University of Geneva, Geneva, Switzerland
| | | | - David Issom
- Institute of Global Health, University of Geneva, Geneva, Switzerland
| | | | | | | | - Egidio Candela
- IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy
| | | | | | - Arianna Dondi
- IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy
| | - Marina Etchebehere
- Faculty of Health Sciences (FICSAE), Hospital Israelita Albert Einstein, São Paulo, Brazil
| | - Gladwell Gathecha
- Department of Non-Communicable Diseases, Ministry of Health (Kenya), Nairobi, Kenya
| | - Andre Pascal Kengne
- Non-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa
| | | | - Benjamin Palafox
- London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom
| | | | | | - Nasheeta Peer
- Non-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa
| | | | - Reza Tabrizi
- Noncommunicable Diseases Research Centre, Fasa University of Medical Sciences, Fasa, Iran
| | - Michel Oris
- Institute of Global Health, University of Geneva, Geneva, Switzerland
| | - David Beran
- University Hospitals of Geneva, Geneva, Switzerland
- Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Dina Balabanova
- London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom
| | | |
Collapse
|
2
|
Sureshkumar S, Mwangi KJ, Gathecha G, Marcus K, Kohlbrenner B, Issom D, Benissa MR, Aebischer-Perone S, Braha N, Candela E, Chhabra KG, Desikachari BR, Dondi A, Etchebehere M, Kengne AP, Missoni E, Mustapha F, Palafox B, Pati S, Madhu PP, Peer N, Quint J, Tabrizi R, Yusoff H, Oris M, Beran DH, Balabanova D, Etter JF. Exploring key-stakeholder perceptions on non-communicable disease care during the COVID-19 pandemic in Kenya. Pan Afr Med J 2023; 44:153. [PMID: 37455892 PMCID: PMC10349631 DOI: 10.11604/pamj.2023.44.153.38616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2022] [Accepted: 03/14/2023] [Indexed: 07/18/2023] Open
Abstract
Introduction over one third of total Disability-Adjusted-Life-Years lost in Kenya are due to non-communicable diseases (NCD). In response, the Government declared significant commitment towards improving NCD care. The COVID-19 pandemic increased the burden on the already overstretched health systems in Kenya. The aims of this study are to assess whether health care providers perceived NCD care to be optimal during the pandemic and explore how to improve responses to future emergencies. Methods this cross-sectional online survey included healthcare personnel with non-clinical roles (public health workers and policy-makers) and those delivering health care (doctors and nurses). Respondents were recruited between May and September 2021 by random sampling, completed by snowball sampling. Results among 236 participants (42% in clinical, 58% in non-clinical roles) there was an overall consensus between respondents on NCD care being disrupted and compromised during the pandemic in Kenya. Detracted supplies, funding, and technical resources affected the continuity of NCDs' response, despite government efforts. Respondents agreed that the enhanced personnel capacity and competencies to manage COVID-19 patients were positive, but noted a lack of guidance for redirecting care for chronic diseases, and advocated for digital innovation as a solution. Conclusion this paper explores the perceptions of key stakeholders involved in the management of NCDs in Kenya to improve planning for future emergency responses. Gaps were identified in health system response and preparedness capacity during the pandemic including the perceived need to strengthen NCD services, with solutions offered to guide resilience efforts to protect the health system from disruption.
Collapse
Affiliation(s)
- Sugitha Sureshkumar
- Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Kibachio Joseph Mwangi
- Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- Department of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
| | - Gladwell Gathecha
- Department of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
| | - Kailing Marcus
- Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - Bogomil Kohlbrenner
- Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - David Issom
- Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | | | | | - Nirit Braha
- Royal Free Hospitals, National Health Service, London, United Kingdom
| | - Egidio Candela
- RCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Kumar Gaurav Chhabra
- Department of Public Health Dentistry, Nims Dental College and Hospital, Nims University, Rajasthan, India
| | | | - Arianna Dondi
- RCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Marina Etchebehere
- Faculdade Israelita de Ciencias da Saude Albert Einstein, Sao Paulo, Brazil
| | - Andre Pascal Kengne
- Non-communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa
| | - Eduardo Missoni
- Center for Research on Health and Social Care Management - CERGAS, SDA Bocconi Management School, Milan, Italy
| | - Feisul Mustapha
- Disease Control Division, Ministry of Health, Putrajaya, Malaysia
| | - Benjamin Palafox
- London School of Hygiene and Tropical Medicine, London, United Kingdom
| | | | - Priyanka Paul Madhu
- Department of Public Health Dentistry, Sharad Pawar Dental College and Hospital, Wardha, India
| | - Nasheeta Peer
- Non-communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa
| | | | - Reza Tabrizi
- Non-Communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
| | - Haironi Yusoff
- Department of Public Health, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Sarawak, Malaysia
| | - Michel Oris
- Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| | - David Henry Beran
- Division of Tropical and Humanitarian Medicine, Faculty of Medicine, University of Geneva, Geneva University Hospitals, Geneva, Switzerland
| | - Dina Balabanova
- London School of Hygiene and Tropical Medicine, London, United Kingdom
| | - Jean-François Etter
- Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
| |
Collapse
|
3
|
Steenblock C, Schwarz PEH, Perakakis N, Brajshori N, Beqiri P, Bornstein SR. The interface of COVID-19, diabetes, and depression. DISCOVER MENTAL HEALTH 2022; 2:5. [PMID: 35253006 PMCID: PMC8886346 DOI: 10.1007/s44192-022-00007-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Accepted: 01/27/2022] [Indexed: 02/07/2023]
Abstract
Comorbid diabetes with depression is a challenging and often under-recognized clinical problem. During the current COVID-19 pandemic, a communicable disease is thriving on the increasing incidences of these non-communicable diseases. These three different health problems are bidirectionally connected forming a vicious cycle. Firstly, depressed individuals show a higher risk of developing diabetes and patients with diabetes have a higher risk of developing symptoms of depression. Secondly, patients with diabetes have a higher risk of developing severe COVID-19 as well as of experiencing breakthrough infections. Thirdly, in both patients with type 2 diabetes and in COVID-19 survivors the prevalence of depression seems to be increased. Fourthly, lockdown and quarantine measurements during the COVID-19 pandemic has led to an increase in depression. Therefore, it is of importance to increase the awareness of this interface between depression, diabetes and COVID-19. Finally, as symptoms of post-COVID, diabetes and depression may be overlapping, there is a need for educating skilled personnel in the management of these comorbidities.
Collapse
Affiliation(s)
- Charlotte Steenblock
- Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
| | - Peter E. H. Schwarz
- Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
- Paul Langerhans Institute Dresden (PLID), Helmholtz Center Munich, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany
- German Center for Diabetes Research (DZD E.V.), Neuherberg, Germany
| | - Nikolaos Perakakis
- Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
- Paul Langerhans Institute Dresden (PLID), Helmholtz Center Munich, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany
- German Center for Diabetes Research (DZD E.V.), Neuherberg, Germany
| | - Naime Brajshori
- Research Unit, Heimerer College, Prishtina, Republic of Kosovo
| | - Petrit Beqiri
- Research Unit, Heimerer College, Prishtina, Republic of Kosovo
| | - Stefan R. Bornstein
- Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
- Paul Langerhans Institute Dresden (PLID), Helmholtz Center Munich, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany
- German Center for Diabetes Research (DZD E.V.), Neuherberg, Germany
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland
- Department of Diabetes, School of Life Course Science and Medicine, Kings College London, London, UK
| |
Collapse
|